In this study we found that HDL from patients with impaired kidney function (CKD stages 3 and 4 and patients on HD treatment) significantly reduced PMNL apoptosis, a response typical of pro-inflammatory mediators [42] such as LPS or IL-18 [43]. Here, IL18 is linked to chronic kidney disease.